Doctor Teona Shvangiradze
Endocrinology Research Center, Moscow (Russian Federation)
Transforming growth factor beta and fibroblast growth factor 21 in cardiovascular prognosis in patients with obesity and type 2 diabetes mellitus
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: Diabetes
Cardiovascular-related microRNAs in patients with obesity and type 2 diabetes mellitus
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: Diabetes
ESC 365 is supported by
